STAAR Surgical Company (STAA)
USD 18.34
(-6.67%)
USD 18.34
(-6.67%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 31.46 Million USD | 15.07% |
| 2022 | 27.34 Million USD | -4.55% |
| 2021 | 28.65 Million USD | 335.76% |
| 2020 | 6.57 Million USD | 47.69% |
| 2019 | 4.45 Million USD | 869.93% |
| 2018 | 459 Thousand USD | -13.56% |
| 2017 | 531 Thousand USD | -60.34% |
| 2016 | 1.33 Million USD | 556.37% |
| 2015 | 204 Thousand USD | -56.41% |
| 2014 | 468 Thousand USD | 231.91% |
| 2013 | 141 Thousand USD | -71.11% |
| 2012 | 488 Thousand USD | -56.58% |
| 2011 | 1.12 Million USD | -19.89% |
| 2010 | 1.4 Million USD | 27.78% |
| 2009 | 1.09 Million USD | -80.9% |
| 2008 | 5.74 Million USD | 4.97% |
| 2007 | 5.47 Million USD | 472.31% |
| 2006 | 957 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 13.7 Million USD | 37.0% |
| 1998 | 10 Million USD | 72.41% |
| 1997 | 5.8 Million USD | 625.0% |
| 1996 | 800 Thousand USD | -33.33% |
| 1995 | 1.2 Million USD | 100.0% |
| 1994 | 600 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | -100.0% |
| 1990 | 700 Thousand USD | -93.27% |
| 1989 | 10.4 Million USD | 19.54% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 35.38 Million USD | 0.0% |
| 2024 Q2 | 31.49 Million USD | 0.0% |
| 2024 Q1 | 31.12 Million USD | 0.0% |
| 2023 Q4 | 31.46 Million USD | -0.82% |
| 2023 FY | 31.46 Million USD | 15.07% |
| 2023 Q3 | 31.72 Million USD | 12.05% |
| 2023 Q2 | 28.31 Million USD | 0.41% |
| 2023 Q1 | 28.19 Million USD | 3.11% |
| 2022 Q3 | 26.28 Million USD | -3.28% |
| 2022 Q2 | 27.17 Million USD | -3.29% |
| 2022 Q4 | 27.34 Million USD | 4.04% |
| 2022 Q1 | 28.1 Million USD | -1.92% |
| 2022 FY | 27.34 Million USD | -4.55% |
| 2021 Q4 | 28.65 Million USD | 47.25% |
| 2021 FY | 28.65 Million USD | 335.76% |
| 2021 Q1 | 6.34 Million USD | -3.51% |
| 2021 Q2 | 8.67 Million USD | 36.81% |
| 2021 Q3 | 19.45 Million USD | 124.2% |
| 2020 FY | 6.57 Million USD | 47.69% |
| 2020 Q4 | 6.57 Million USD | 16.5% |
| 2020 Q3 | 5.64 Million USD | 64.64% |
| 2020 Q2 | 3.42 Million USD | -8.44% |
| 2020 Q1 | 3.74 Million USD | -15.9% |
| 2019 Q4 | 4.45 Million USD | -0.49% |
| 2019 FY | 4.45 Million USD | 869.93% |
| 2019 Q2 | 5.16 Million USD | 4.75% |
| 2019 Q3 | 4.47 Million USD | -13.29% |
| 2019 Q1 | 4.92 Million USD | 973.2% |
| 2018 Q4 | 459 Thousand USD | -30.66% |
| 2018 Q1 | 1.15 Million USD | 117.14% |
| 2018 FY | 459 Thousand USD | -13.56% |
| 2018 Q2 | 868 Thousand USD | -24.72% |
| 2018 Q3 | 662 Thousand USD | -23.73% |
| 2017 Q1 | 1.42 Million USD | 6.42% |
| 2017 Q2 | 1.12 Million USD | -20.84% |
| 2017 Q3 | 834 Thousand USD | -26.06% |
| 2017 FY | 531 Thousand USD | -60.34% |
| 2017 Q4 | 531 Thousand USD | -36.33% |
| 2016 FY | 1.33 Million USD | 556.37% |
| 2016 Q3 | 1.67 Million USD | 21.1% |
| 2016 Q2 | 1.38 Million USD | 1072.88% |
| 2016 Q1 | 118 Thousand USD | -42.16% |
| 2016 Q4 | 1.33 Million USD | -20.11% |
| 2015 Q4 | 204 Thousand USD | -8.93% |
| 2015 FY | 204 Thousand USD | -56.41% |
| 2015 Q1 | 411 Thousand USD | -12.18% |
| 2015 Q2 | 305 Thousand USD | -25.79% |
| 2015 Q3 | 224 Thousand USD | -26.56% |
| 2014 Q2 | 629 Thousand USD | 428.57% |
| 2014 Q1 | 119 Thousand USD | -15.6% |
| 2014 FY | 468 Thousand USD | 231.91% |
| 2014 Q4 | 468 Thousand USD | -13.01% |
| 2014 Q3 | 538 Thousand USD | -14.47% |
| 2013 Q3 | 211 Thousand USD | -23.55% |
| 2013 Q1 | 346 Thousand USD | -29.1% |
| 2013 FY | 141 Thousand USD | -71.11% |
| 2013 Q4 | 141 Thousand USD | -33.18% |
| 2013 Q2 | 276 Thousand USD | -20.23% |
| 2012 Q2 | 712 Thousand USD | -3.26% |
| 2012 Q3 | 534 Thousand USD | -25.0% |
| 2012 Q4 | 488 Thousand USD | -8.61% |
| 2012 FY | 488 Thousand USD | -56.58% |
| 2012 Q1 | 736 Thousand USD | -34.52% |
| 2011 FY | 1.12 Million USD | -19.89% |
| 2011 Q3 | 990 Thousand USD | -26.17% |
| 2011 Q2 | 1.34 Million USD | -0.96% |
| 2011 Q1 | 1.35 Million USD | -3.49% |
| 2011 Q4 | 1.12 Million USD | 13.54% |
| 2010 FY | 1.4 Million USD | 27.78% |
| 2010 Q4 | 1.4 Million USD | 7.35% |
| 2010 Q1 | 730 Thousand USD | -33.52% |
| 2010 Q2 | 687 Thousand USD | -5.89% |
| 2010 Q3 | 1.3 Million USD | 90.25% |
| 2009 Q1 | 1.21 Million USD | -78.94% |
| 2009 Q2 | 5.45 Million USD | 350.7% |
| 2009 FY | 1.09 Million USD | -80.9% |
| 2009 Q4 | 1.09 Million USD | -79.94% |
| 2009 Q3 | 5.47 Million USD | 0.27% |
| 2008 Q2 | 5.59 Million USD | 3.17% |
| 2008 Q1 | 5.41 Million USD | -1.08% |
| 2008 FY | 5.74 Million USD | 4.97% |
| 2008 Q4 | 5.74 Million USD | 3.96% |
| 2008 Q3 | 5.53 Million USD | -1.07% |
| 2007 Q1 | 4.89 Million USD | 411.08% |
| 2007 FY | 5.47 Million USD | 472.31% |
| 2007 Q4 | 5.47 Million USD | 319.69% |
| 2007 Q3 | 1.3 Million USD | -7.97% |
| 2007 Q2 | 1.41 Million USD | -71.01% |
| 2006 FY | 957 Thousand USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | 957 Thousand USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 Q3 | 181.37 Thousand USD | 0.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q1 | 17.62 Million USD | 28.66% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | 181.37 Thousand USD | -98.97% |
| 1999 Q3 | 12.3 Million USD | 16.04% |
| 1999 Q2 | 10.6 Million USD | 2.91% |
| 1999 Q1 | 10.3 Million USD | 3.0% |
| 1999 FY | 13.7 Million USD | 37.0% |
| 1999 Q4 | 13.7 Million USD | 11.38% |
| 1998 FY | 10 Million USD | 72.41% |
| 1998 Q3 | 9.6 Million USD | 18.52% |
| 1998 Q4 | 10 Million USD | 4.17% |
| 1998 Q1 | 6.5 Million USD | 12.07% |
| 1998 Q2 | 8.1 Million USD | 24.62% |
| 1997 FY | 5.8 Million USD | 625.0% |
| 1997 Q1 | 700 Thousand USD | -12.5% |
| 1997 Q2 | 4.6 Million USD | 557.14% |
| 1997 Q3 | 3 Million USD | -34.78% |
| 1997 Q4 | 5.8 Million USD | 93.33% |
| 1996 Q3 | 1 Million USD | -9.09% |
| 1996 Q1 | 1.3 Million USD | 8.33% |
| 1996 FY | 800 Thousand USD | -33.33% |
| 1996 Q4 | 800 Thousand USD | -20.0% |
| 1996 Q2 | 1.1 Million USD | -15.38% |
| 1995 Q2 | 1.1 Million USD | 10.0% |
| 1995 Q4 | 1.2 Million USD | 9.09% |
| 1995 FY | 1.2 Million USD | 100.0% |
| 1995 Q1 | 1 Million USD | 66.67% |
| 1995 Q3 | 1.1 Million USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | 600 Thousand USD | 0.0% |
| 1994 Q4 | 600 Thousand USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q1 | 600 Thousand USD | -14.29% |
| 1991 FY | - USD | -100.0% |
| 1990 FY | 700 Thousand USD | -93.27% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1989 FY | 10.4 Million USD | 19.54% |
| 1989 Q4 | 10.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 58.186% |
| AngioDynamics, Inc. | 3.93 Million USD | -698.858% |
| AtriCure, Inc. | 60.59 Million USD | 48.068% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 47.933% |
| BioLife Solutions, Inc. | 18.31 Million USD | -71.848% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 98.753% |
| Daxor Corporation | 755.65 Thousand USD | -4064.18% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -551.221% |
| Femasys Inc. | 4.25 Million USD | -638.978% |
| GlucoTrack, Inc. | 196 Thousand USD | -15954.592% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -2.485% |
| Hologic, Inc. | 2.49 Billion USD | 98.74% |
| ICU Medical, Inc. | 1.57 Billion USD | 98.006% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 138.328% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -761.42% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -89.287% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 96.39% |
| Microbot Medical Inc. | 40 Thousand USD | -78567.5% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -685156.969% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 96.177% |
| Nephros, Inc. | 1.39 Million USD | -2163.813% |
| NovoCure Limited | 596.24 Million USD | 94.722% |
| NEXGEL, Inc. | 513 Thousand USD | -6033.918% |
| NEXGEL, Inc. | 513 Thousand USD | -6033.918% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 53.399% |
| OraSure Technologies, Inc. | 11.38 Million USD | -176.317% |
| Pro-Dex, Inc. | 7.53 Million USD | -317.556% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -289.154% |
| Predictive Oncology Inc. | 2.18 Million USD | -1337.52% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -1523.709% |
| QuidelOrtho Corporation | 2.27 Billion USD | 98.616% |
| Repligen Corporation | 510.14 Million USD | 93.832% |
| Sanara MedTech Inc. | 9.11 Million USD | -245.293% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -10566.78% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 98.248% |
| Jin Medical International Ltd. | - USD | -Infinity% |